北京丙肝医院丙肝标准治疗__培训课件.pptVIP

Slide *. 48 weeks’ PEGASYS? plus COPEGUS? is better than 24 weeks in genotype 1 Results from the individualised treatment trial conducted by Hadziyannis, et al. showed that longer durations of treatment (48 weeks) and standard ribavirin doses (1000–1200 mg/day) were both associated with higher sustained virological response (SVR) among patients infected with HCV genotype 1. Reducing either the duration of treatment or the daily dose of COPEGUS? led to a reduction in efficacy. PEGASYS? plus COPEGUS? is the first and only pegylated interferon plus ribavirin combination therapy to provide an ove